[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370587-105":59,"doc-detail-370587-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","nox4-as-an-emerging-prognostic-and-immunological-biomarker-across-pan-cancer-analyses","NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses","","NOX4’s prognostic and immunological significance across cancer types remains insufficiently characterized despite extensive evidence for its involvement in malignancies. This study integrates pan-cancer expression and outcome evaluation using multiple public databases, assessing clinical correlations, genetic variants, tumor microenvironment interactions, immune relevance, therapeutic potential, and related gene functions via multi-omics approaches. Clinical validation uses immunohistochemistry, H&E staining, and RT-PCR. NOX4 is overexpressed in many tumors but decreased in certain renal cancers, correlating with prognosis and immune infiltration, with associations involving immune checkpoints and multiple genomic and epigenomic biomarkers.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nox4-as-an-emerging-prognostic-and-immunological-biomarker-across-pan-cancer-analyses/370587/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nox4-as-an-emerging-prognostic-and-immunological-biomarker-across-pan-cancer-analyses/370587.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What key relationships were reported between NOX4 and patient outcomes?","Question",{"text":112,"@type":113},"NOX4 expression was linked to distinct patient prognosis patterns and showed significant association with tumor immune infiltration. It also correlated with immune checkpoint proteins and multiple genomic and epigenomic features such as TMB and MSI.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},370587,1790536109,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses  \nYusheng Liu1, Chunying Wu1, Qiang Wang1, Xiaoshan Zhao1,2􀀍 & Xuefeng Jiang1,2􀀍  \nDespite extensive research highlighting the pivotal role of NOX4 in the development of various malignancies, no systematic pan-cancer analysis has been conducted to evaluate its comprehensive prognostic value and potential immunological functions. In this study, we explored the prognostic significance of NOX4 and its role in immune modulation across different cancer types. We performed a pan-cancer analysis of NOX4 expression and its prognostic implications using multiple databases, including TCGA, GEPIA, GTEx, UALCAN, TISCH, GDSC, PDB, TIMER, and cBioPortal. This analysis provided a detailed assessment of NOX4 expression profiles, clinical correlations, genetic variants, tumor microenvironment interactions, immune relevance, therapeutic potential, and related  \ngene functions through various multi-omics approaches. To further investigate these findings, we collected clinical samples from selected cancer types and validated NOX4 expression through immunohistochemistry, H&E staining, and RT-PCR. Our results revealed that NOX4 was overexpressed in most tumors, although its expression was significantly reduced in certain renal cancers. Moreover, we observed distinct correlations between NOX4 expression and patient prognosis. Notably, NOX4 expression was significantly associated with tumor infiltration, indicating its potential as a target for immunotherapy. Additionally, NOX4 expression showed significant correlations with immune checkpoint proteins (ICP), tumor mutation burden (TMB), microsatellite instability (MSI), RNA stemness scores (RNAss), DNA stemness scores (DNAss), RNA methylation, and DNA methylation.  \nKeywords NOX4, Pan-cancer, Prognosis, Immune microenvironment  \nThe World Health Organization (WHO) reports that cancer is the second leading cause of death globally, responsible for approximately 10 million deaths annually. Cancer accounts for roughly one-sixth of all deaths worldwide1. Beyond these statistics, each case represents the profound impact on individuals and families, who face significant emotional, financial, and healthcare challenges. The growth of large biological databases, advancements in high-throughput technologies (e.g., genomics, proteomics, and metabolomics)2, and the development of novel assays have enabled a wealth of studies that provide new insights into genome-wide analyses and the identification of biomarkers for early detection of pan-cancer. These biomarkers include gene mutations, RNA alterations, driver genes, and copy number variations. In recent years, the ability to trace tumor origins has improved, facilitating earlier detection and potentially aiding in the prediction of clinical outcomes3. Currently, a variety of cancer treatment options are available, including chemotherapy, surgery, radiotherapy, immunotherapy, and targeted therapy. Pan-cancer analysis can identify both shared and unique characteristics across different tumors, offering valuable insights for cancer prevention, therapeutic target development, and the discovery of novel biomarkers4.  \nNADPH oxidases, members of the NOX family, are electron transport enzymes that function through the inner cell membrane. The NOX family was first identified in the membranes of phagocytes. Currently, the NOX family consists of seven members (NOX1-5 and DUOX1-2)5. Dysregulation of NOX members has been widely observed in cancer models, with NOX4 being the most commonly implicated. NOX4 is a homolog of the phagocyte NADPH oxidase GP91 PHOX (NOX2), and its unique enzymatic activity generates reactive oxygen species (ROS), exhibiting a cell-specific expression pattern across various organs. NOX4 produces ROS in a temporally and spatially regulated manner in response to specific extracellular and","cbCaiqAph09TBibl","https://ap.wps.com/l/cbCaiqAph09TBibl","pdf",12199508,22,"English","# Introduction\n## NOX4 biology and relevance to cancer\n## Rationale for pan-cancer analysis\n# Methods and validation\n## Database-based pan-cancer analysis\n## Clinical sample validation\n# Results\n## Expression patterns across tumors\n## Prognostic and immune associations","[{\"question\":\"What key relationships were reported between NOX4 and patient outcomes?\",\"answer\":\"NOX4 expression was linked to distinct patient prognosis patterns and showed significant association with tumor immune infiltration. It also correlated with immune checkpoint proteins and multiple genomic and epigenomic features such as TMB and MSI.\"}]","NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses | PDF",1790189337,55,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20f406ccb9b69ff85d74e2811bcb06da.webp",983,1291,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ad38f351a54e75f9efd48a35506b78.webp",982,1290,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4616a17d39a6d7ec2035637b058aeb14.webp",981,1289,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d1a67b82907342bbf8fc6ede5afa085.webp",980,1287]